OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
January 28, 2022
IonSense’s DART-MS technology offers rapid drug analysis without the need for sample preparation.
Texcell North America’s new lab facility in Frederick, Md., will expand the CRO’s capabilities in R&D cell culture, viral clearance studies, and viral safety testing.
PhoreMost has entered into separate collaboration agreements with Polaris Quantum Biotech and NeoCura Bio-Medical Technology to discover and develop novel cancer therapeutics.
January 18, 2022
In their collaboration, Bristol Myers Squibb and Prellis Biologics aim to generate human antibody libraries for select targets to enable drug discovery.
After a previously announced merger, Protagen Protein Services, BioAnalytix, and GeneWerk have formed a new CRO under the name ProtaGene.
January 13, 2022
Fujifilm Diosynth Biotechnologies' 89,000 square-foot expansion of its BioProcess Innovation Center in Research Triangle Park, N.C., will double its capacity to support process characterization.
January 07, 2022
The acquisition of Protein Metrics expands Insightful Science’s R&D solutions to include proteomics.
January 05, 2022
Persistent bottlenecks in biocatalyst development can be alleviated through fully automated enzyme analysis.
January 02, 2022
There is need for training personnel in various analytical skill sets for biologic drug substance testing.
December 17, 2021
Amgen and Syngene International have extended their research collaboration to 2026.